On Wednesday, June 27, a Denver based federal jury granted $383.5 million to the families of patients who passed away from being treated at DaVita Inc.
Three patients had been suffering from cardiac arrests and were immediately sent to DaVita Inc. for treatment.
The patients Irma Menchaca, Gary Saldana, and Deborah Hardin were sent to DaVita Inc. for treatment, however, they ended up passing away. The families of these patients filed a lawsuit against DaVita.
Lawyers representing this case helped the families understand that the product GranuFlo was used on the patients, which is a product that may cause toxic pH imbalances in a patient’s body.
The families were awarded $2 million, $1.5 million and $5 million for compensatory damages. They were also awarded $125 million for punitive damages.
However, despite the jury’s decision, DaVita is appealing and disagrees with the statement that the jurors decided on.
The jury believes that DaVita hid information from the patients about the product, which is why they claimed DaVita guilty of negligence and wrongful death.
In 2012, the U.S. Food and Drug Administration released for their customers to return GranuFlo.
GranuFlo is a product that eliminates bad products in a person’s blood and helps keep a proper pH balance. However, the acetate that is in GranuFlo could cause horrible side effects that lead to a stroke or heart attack, which lawyers explained to the family members of the patients who suffered the side effects.
Families of the patients argued that “DaVita ignored many red flags that preceded the loss of life of these three patients and many others.”